Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 140
Filter
1.
Singapore Med J ; 50(3): 288-94, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19352573

ABSTRACT

INTRODUCTION: During the month of Ramadan, fasting is obligatory for all healthy adult Muslims, with the only exempted adults being those who have to travel or are sick. The aim of this study was to see whether changes in food intake and meal patterns during Ramadan fasting could modify serum lipid and lipoprotein parameters in healthy Algerian young men and women volunteers. The time-course prospective study was done in order to investigate at what time eventual changes to these parameters occur during Ramadan and their disappearance after Ramadan. METHODS: Subjects were interviewed by trained interviewers using the method of the "seven day recall and record", before, during and after Ramadan. The serum lipid and lipoprotein contents were analysed at different times. RESULTS: The total energy intake was higher during Ramadan (13 and 11 MJ/day) than before and after Ramadan (11 and 9 MJ/day) in men and women, respectively. In the second week of Ramadan, carbohydrate intake was elevated by 22 percent and 24 percent in men and women, respectively, compared to before and after Ramadan. At the end of Ramadan, the low density lipoproteins (LDL) percentages decreased by 20 percent in women and 55 percent in men compared to the values obtained before Ramadan. In both groups, the amount of serum high density lipoproteins (HDL) was 1.4-fold higher, in particular on day 28 of Ramadan, in comparison with the period before and after Ramadan. Indeed, a progressive decrease in LDL-C was noted in women and was particularly drastic in men. In contrast, HDL-C had increased by 30 percent on day 15 of Ramadan, compared to before Ramadan. CONCLUSION: This study shows that striking changes in nutritional habits during Ramadan may be useful in reducing LDL levels and in increasing HDL levels. The young Muslim's diet during Ramadan may contribute to favourable modifications of the serum lipoprotein profile related to cardiovascular protection.


Subject(s)
Fasting , Holidays , Islam , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Nutritional Status , Triglycerides/blood , Adult , Age Factors , Algeria , Apolipoproteins/blood , Body Weight , Dietary Carbohydrates , Female , Humans , Male , Prospective Studies , Time Factors
2.
Eur J Pediatr ; 167(5): 525-32, 2008 May.
Article in English | MEDLINE | ID: mdl-17605041

ABSTRACT

The aim of this study was to determine serum lecithin:cholesterol acyltransferase (LCAT) activity in parallel with HDL2 and HDL3 amounts and composition in pregnancy induced hypertension (PIH) and chronic hypertensive (CH) mothers and in their small for gestational age (SGA) newborns. LCAT activity was assayed by conversion of [3H] cholesterol to labelled cholesteryl ester. HDL2 and HDL3 were separated by ultracentrifugation. At term, cholesterol values were similar in PIH, CH and controls. However, higher levels of triglycerides were observed in PIH and CH (+20% and +21%, respectively) as compared with normotensive control mothers (NC). HDL2 and HDL3-phospholipids, HDL2-cholesterol concentrations and LCAT activity were lower in PIH and CH mothers than in NC mothers. Similar changes were also observed in SGA newborns of PHI mothers and in SGA newborns of CH mothers when compared to appropriate for gestational age newborns of control mothers (AGA-NC). In addition, SGA newborns showed low HDL2 and HDL3 apoA-I contents. Maternal hypertension and foetal intrauterine growth retardation are associated with profound abnormalities in HDL metabolism, consistent with an atherogenic risk. SGA lipoprotein profiles appear to implicate later metabolic diseases.


Subject(s)
Cholesterol, HDL/blood , Hypertension/blood , Infant, Small for Gestational Age/blood , Metabolic Diseases/etiology , Phosphatidylcholine-Sterol O-Acyltransferase/blood , Biomarkers/blood , Female , Humans , Hypertension/physiopathology , Hypertension, Pregnancy-Induced/blood , Hypertension, Pregnancy-Induced/physiopathology , Immunoenzyme Techniques , Incidence , Infant, Newborn , Male , Metabolic Diseases/epidemiology , Pregnancy , Prognosis , Risk Factors
3.
Arch Mal Coeur Vaiss ; 99(7-8): 679-82, 2006.
Article in French | MEDLINE | ID: mdl-17061443

ABSTRACT

Placenta lipoprotein lipase (LPL) activity as well as serum VLDL and placenta lipids composition were determined in pregnant hypertensive women at term. 46 patients aged from 29 +/- 2 years with gravidic hypertension (HTA-G) and 38 patients with essential hypertension (HTA-E) aged 30 +/- 1 years were compared with 20 normotensive women aged 27 +/- 1 years. Serum triacylglycerols (TG) concentrations were 1.3-fold higher in the both hypertensive patients compared with controls. However, serum phospholipids (PL) and total cholesterol (TC) values were similar in the three groups. VLDL mass and their apolipoproteins, unesterified cholesterol (UC) and cholesteryl esters (CE) contents were significantly increased in hypertensive women compared with controls. In HTA-G and HTA-E patients, respectively. TG-VLDL concentrations were increased by +43% and +36% compared with those of controls (P < 0.01). In placenta, the values were lower 2.2- and 1.9-fold for TG, 2.8 and 2.5-fold for PL and two- and threefold for TC, in HTA-G and HTA-E patients than in controls. Placenta LPL activity was 2.7-fold higher in HTA-G and HTA-E patients compared with that of controls. In conclusion, although placenta LPL activity is higher it is not permit a decrease of serum TG-VLDL on the one hand, and an increase of placenta ability in TG storage on the other hand.


Subject(s)
Hypertension, Pregnancy-Induced/metabolism , Lipoprotein Lipase/metabolism , Placenta/metabolism , Triglycerides/metabolism , Adult , Case-Control Studies , Cholesterol/blood , Female , Humans , Hypertension/metabolism , Pregnancy , Triglycerides/blood
4.
Arch Mal Coeur Vaiss ; 99(7-8): 727-31, 2006.
Article in French | MEDLINE | ID: mdl-17061453

ABSTRACT

Fish proteins effect compared with casein was determined on triacylglycerols (TG) metabolism and activities of hepatic triacylglycerol lipase (HTGL) and tissue lipoprotein lipases (LPL), in SHR and diabetic SHR. Two groups of rats (n=24) were fed, 2 months, diet containing 20% casein (CAS) or 20% fish proteins (FP). One month before sacrifice, diabetes was induced in one group of rats by a single intraperitoneal injection of streptozotocin (STZ) (60 mg/kg of body weight). FP vs. CAS showed a significant decrease of TG concentrations in plasma (-41%) and liver (-66%), in SHR-STZ. VLDL-LDL mass, which represented the amount of apolipoproteins, TG, phospholipids (PL), unesterified cholesterol (UC), and cholesteryl esters (CE), decreased by 21 and 16% with FP vs. CAS, in SHR and SHR-STZ, respectively, and was concomitant with its low TG. Indeed, TG values was 1.35- and 1.82-fold lower in SHR and SHR-STZ, respectively. In HDL2, a TG diminution of 13% was noted, in SHR with FP vs. CAS. In SHR-STZ with FP, TG and PL were enhanced by 11% and 27%, respectively compared to SHR. HTGL activity decreased by 22% in SHR fed FP compared to those fed CAS. In SHR-STZ with CAS vsSHR, this activity was decreased by 21%. LPL activity in heart was enhanced by 19% in SHR-STZ vs. SHR with FP, when that of muscle was diminished 1.5-fold in SHR with FP vs. CAS and 1.8-fold in SHR-STZ vs. SHR with CAS. Adipose LPL activity was 1.36-fold higher in SHR with FP than CAS. In conclusion, it appears that fish proteins have a hypotriglyceridemic effect, which the mechanism can differ in SHR or SHR-STZ. It may be of interest to propose these fish proteins as lipid metabolism regulator in diseases with hypertriglyceridemia.


Subject(s)
Cholesterol/blood , Diabetes Mellitus, Experimental/metabolism , Fish Proteins/pharmacology , Hypertension/metabolism , Liver/metabolism , Triglycerides/metabolism , Animals , Caseins/pharmacology , Chelating Agents/pharmacology , Diet , Male , Rats
5.
Gen Physiol Biophys ; 25(3): 277-87, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17197726

ABSTRACT

Aziridines have been shown to possess marked immunotropic activity. The aim of this work was to study the in vitro effects of different concentrations of three novel aziridines, 2-hydroxy-methyl-1-(N-phtaloylglycyl) aziridine (aziridine 1), 2-hydroxy-methyl-1-(N-phtaloylalanyl) aziridine (aziridine 2) and 2-hydroxy-methyl-1-(N-phtaloylphenylalanyl) aziridine (aziridine 3), on the proliferative responses of human lymphocytes stimulated by mitogens (concanavalin A (Con A) and lipopolysaccharide (LPS)), and interleukin-2 (IL-2), interleukin-6 (IL-6) secretion. The results showed that aziridines 1 and 3 significantly stimulated the resting and Con A or LPS lymphocyte proliferation at concentrations between 1 micromol/l and 1 mmol/l, in a dose-dependent manner, the action of aziridine 3 being the highest. They also increased IL-2 and IL-6 secretion. However, aziridine 2 had no effect on the resting lymphocyte proliferation in the absence of mitogens, at any concentration used, reduced Con A-stimulated T lymphocyte proliferation and LPS- stimulated B lymphocyte proliferation in a dose dependent manner and diminished IL-2 and IL-6 production. None of the three aziridines affected cell viability. In conclusion, the three aziridines used in this study displayed immunomodulatory properties. Aziridines 1 and 3 are potentially immunostimulant while aziridine 2 is immunosuppressive and could be used to provide nonspecific cell-mediated immune responses.


Subject(s)
Aziridines/pharmacology , Lymphocytes/cytology , Lymphocytes/drug effects , Aziridines/chemistry , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Cell Proliferation/drug effects , Concanavalin A/pharmacology , Humans , Immunologic Factors/chemistry , Immunologic Factors/pharmacology , In Vitro Techniques , Interleukin-2/biosynthesis , Interleukin-6/biosynthesis , Lipopolysaccharides/pharmacology , Lymphocyte Activation/drug effects , Lymphocytes/immunology , Mitogens/pharmacology , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology
6.
Eur J Nutr ; 44(1): 10-7, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15309459

ABSTRACT

The two-month effects of dietary fish protein and casein on VLDL, HDL(2) and HDL(3) compositions and hepatic lipase (HTGL) and tissue lipoprotein lipase (LPL) activities were examined in spontaneously hypertensive rats (SHR) at 4 wk of age. After 2 mo of experiment, the fish protein diet induced lower blood pressure (-14 %) as compared to casein. Liver triacylglycerol and total cholesterol concentrations were 1.37- and 1.71-fold lower in the fish protein group than in the casein group, respectively. Total cholesterol concentration in plasma was also diminished by fish protein (-21 %) and was reflected in HDL(2) fraction (-44 %). SHR fed the fish protein diet as compared with those fed casein, showed a significantly low HDL(3) particle number, as measured by diminished HDL(3) mass and apo A-I. The consumption of fish protein did not affect VLDL particle number, but significantly decreased VLDL-triacylglycerol (-32 %) and adipose tissue total lipid concentrations as compared to casein. This was accompanied by diminished HTGL and adipose tissue LPL activities (-10%, -91%, respectively). These data demonstrate that fish protein plays an antihypertensive role and reduces plasma and tissue lipid concentrations. Thus, a fish protein intake might be beneficial for patients with hypertension.


Subject(s)
Blood Pressure/drug effects , Fish Proteins/pharmacology , Lipoprotein Lipase/drug effects , Lipoproteins, HDL/drug effects , Animals , Biomarkers/blood , Body Weight/drug effects , Caseins/pharmacology , Cholesterol/metabolism , Cholesterol, VLDL/drug effects , Eating , Kidney/metabolism , Lipase/drug effects , Lipase/metabolism , Lipoprotein Lipase/metabolism , Lipoproteins, HDL/metabolism , Lipoproteins, HDL2 , Lipoproteins, HDL3 , Liver/metabolism , Male , Models, Animal , Myocardium/metabolism , Organ Size , Rats , Rats, Inbred SHR , Triglycerides/metabolism
7.
Arch Mal Coeur Vaiss ; 97(7-8): 734-8, 2004.
Article in French | MEDLINE | ID: mdl-15506056

ABSTRACT

Fish protein (FP) effect compared to casein (CAS) was studied on blood pressure (BP) evolution and glycemia in part, and on plasma lipid, angiotensine II and aldosterone concentrations and urinary aldosterone on the other hand, in SHR and in SHR with streptozotocin-induced diabetes (SHR-STZ). Two groups of rats (6 SHR and 6 SHR-STZ) were fed for 2 months diet containing 20% CAS or 20% FP. One month before sacrifice, diabetes was induced into one group of rats by a single intraperitonealy injection of streptozotocin (STZ). The results showed that FP diminished blood pressure (-9%) in SHR, compared with CAS. In contrast, FP enhanced significantly blood pressure in SHR-STZ vs SHR (p<0.01). There was no effect on glycemia with fish protein. FP compared to CAS involved a diminution (-41%) and (-17%) of total cholesterol and (-26%) and (-9%) of phospholipids in SHR and SHR-STZ, respectively. Moreover, a decrease of triacylglycerols (-21%) was noted in SHR-STZ with FP vs CAS. In SHR, plasma aldosterone and angiotensine II concentrations were reduced (-62%) and (-64%) and urinary aldosterone amounts were enhanced with FP compared to CAS (p<0.05). In SHR-STZ group, aldosterone value was fivefold lower in plasma and twofold higher in urine with FP compared to CAS. A significant enhancement of urinary aldosterone was noted in SHR-STZ vs SHR whatever diet-consumed. In conclusion, FP has a beneficial effect on blood pressure by modulating the hypertension markers i.e. plasma total cholesterol, angiotensine II and aldosterone, in SHR group, and on total cholesterol and triglycerids in SHR-STZ. FP reduces plasma aldosterone by its enhanced urinary excretion. It is necessary to specify the action mode of FP in order to propose it as nutritional complement in the degenerative diseases such as hypertension and diabetes.


Subject(s)
Blood Pressure , Caseins/pharmacology , Diabetes Mellitus/physiopathology , Dietary Proteins/pharmacology , Fishes , Aldosterone/blood , Angiotensin II/blood , Animal Feed , Animals , Blood Glucose , Disease Models, Animal , Lipids/blood , Male , Rats , Rats, Inbred SHR
8.
Int J Sports Med ; 24(1): 51-6, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12582952

ABSTRACT

To examine neuromuscular fatigue and recovery following an isokinetic fatiguing exercise, nine active females performed a fatiguing exercise comprising of ten sets of ten maximal concentric knee extensions. Before (pre-test), five minutes (post-test), 24 h and 48 h after the fatiguing exercise, maximal voluntary eccentric (-1.05 rad x s(-1); -2.09 rad x s(-1)), isometric (0 rad x s(-1)) and concentric (1.05 rad x s(-1); 2.09 rad x s(-1)) torque were measured. In order to distinguish central from peripheral factors involved in torque decrement, activation level (twitch interpolation technique) and twitch contractile properties were recorded. During the course of the fatiguing exercise, concentric torque was significantly lower during the 3rd set than pre-test (-5.6 +/- 12.3 %) and further decreased to the 10th (-10.3 +/- 9.5 %). Eccentric and isometric torques were significantly lower during post-test than pre-test (-16.8 +/- 8.8 % at -2.09 rad x s(-1), -15.1 +/- 7.4 % at -1.05 rad x s(-1), and -10.4 +/- 5.9 % at 0 rad x s(-1); p < 0.05), while concentric torque was not significantly modified. Voluntary activation, peak twitch torque, twitch maximal rates of force development and relaxation were also significantly declined (p < 0.05) at post-test. Twenty-four hours later, all the measured parameters were close to their pre-fatigue values. The present results reveal that the best way to test concentric-induced alteration of neuromuscular function was to use stressful testing conditions, such as eccentric contractions.


Subject(s)
Exercise/physiology , Isometric Contraction/physiology , Muscle, Skeletal/physiology , Torque , Adult , Electromyography , Female , Humans , Knee/physiology , Muscle Fatigue/physiology , Physical Education and Training/methods , Recovery of Function , Time
9.
Ann Nutr Metab ; 46(3-4): 139-46, 2002.
Article in English | MEDLINE | ID: mdl-12169857

ABSTRACT

The aim of this study was to determine the effect of age, overweight and food consumption on the number and size of cholesterol stones and bile composition in west Algerian women undergoing surgery for cholelithiasis. Patients were divided into four groups according to body mass index (BMI, weight/height(2), kg/m(2)) and age. The highest number of patients with cholesterol gallstones was observed in the older women, in particular in those being overweight. In all patients, the stone number and size was approximately similar. The same dietary consumption was observed in older and young patients. Overweight patients were characterized by higher energy consumption (14.5 +/- 2.0 MJ x day(-1)) versus normal-weight patients (10.6 +/- 1.3 MJ x day(-1); p < 0.01) and versus Mediterranean diet (8 MJ x day(-1)). In normal-weight patients, the cholesterol saturation index (CSI) was higher in older patients (+56%) versus young patients while it diminished (-53%) in older overweight versus young patients. In older patients, the CSI was fourfold higher in normal-weight compared to overweight patients (p < 0.001). In conclusion, differences in food consumption were noted in overweight patients compared to normal-weight patients. Advanced age and overweight impaired biliary lipid composition, increased the number of patients with cholesterol gallstones but did not significantly affect the physical characteristics of west Algerian women.


Subject(s)
Bile/chemistry , Cholelithiasis/chemistry , Cholelithiasis/surgery , Cholesterol/analysis , Diet/adverse effects , Lipids/analysis , Obesity/complications , Adult , Age Factors , Algeria , Analysis of Variance , Body Mass Index , Female , Humans , Middle Aged
10.
FASEB J ; 15(14): 2595-601, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11726535

ABSTRACT

We synthesized diacylglycerols (DAGs) containing omega-6 or omega-3 polyunsaturated fatty acids [i.e., 1-stearoyl-2-arachidonoyl-sn-glycerol (SAG), 1-stearoyl-2-docosahexaenoyl-sn-glycerol (SDG), and 1-stearoyl-2-eicosapentaenoyl-sn-glycerol (SEG)] and assessed their efficiency on activation of conventional (alpha, beta I, gamma) and novel (epsilon, delta) protein kinase C (PKC). SAG exerted significantly higher stimulatory effects than SDG and SEG on activation of PKC alpha and PKC delta. Activation of PKC beta I by SEG and SDG was higher than that by SAG. Activation of PKC gamma did not differ significantly among DAG molecular species. Addition of SAG to assays containing SEG and SDG exerted additive effects on activation of alpha and epsilon, but not on beta I and gamma, isoforms of PKC. SDG- and SEG-induced activation of PKC delta was significantly curtailed by the addition of SAG. Three DAG species significantly curtailed the PMA-induced activation of beta Iota, gamma, and delta, but not of alpha and epsilon, isoforms of PKC. Our study demonstrates for the first time that in vitro activation of different PKC isoenzymes vary in response to different DAG species, and one can envisage that this differential regulation may be responsible for their in vivo effects on target organs.


Subject(s)
Diglycerides/pharmacology , Protein Kinase C/metabolism , Diglycerides/chemistry , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Isoenzymes/metabolism , Phosphatidylserines/pharmacology , Protein Kinase C beta , Protein Kinase C-alpha , Protein Kinase C-delta , Protein Kinase C-epsilon , Structure-Activity Relationship , Tetradecanoylphorbol Acetate/pharmacology
11.
J Lipid Res ; 42(7): 1152-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11441144

ABSTRACT

The aim of this study was to determine the impact of diabetic macrosomia on cholesterol and lipoprotein metabolism. Age-related changes in the activities of serum LCAT, hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and ACAT, the major enzymes involved in cholesterol metabolism, were determined in macrosomic offspring of streptozotocin-induced diabetic rats. Hepatic, serum, and lipoprotein cholesterol contents were also examined. Mild hyperglycemia in pregnant rats was induced by intraperitoneal injection of streptozotocin (40 mg/kg body weight) on day 5 of gestation. Control pregnant rats were injected with citrate buffer. At birth, macrosomic pups had higher serum, LDL-HDL(1), and HDL(2-3) cholesterol levels (P < 0.05) associated with increased LCAT activity (+57%) compared with control values. At 1 and 2 months of life, serum and lipoprotein cholesterol concentrations in macrosomic rats were similar to those of controls, whereas LCAT activity remained elevated about 1.5-fold. In addition, there was no change in hepatic cholesterol contents but hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and ACAT activities were higher in both macrosomic males and females than in their respective controls (P < 0.01). By 3 months, macrosomic rats had developed hypercholesterolemia with a rise in all lipoproteins. Enzyme activities were still increased in these mature macrosomic rats, and hepatic cholesteryl esters were higher only in macrosomic females. These data demonstrate an overproduction, combined with overutilization, of cholesterol during the phase of rapid growth in macrosomic rats. However, cholesterol oversynthesis exceeded its removal and was a major contributor to hypercholesterolemia in adult macrosomic rats. In conclusion, macrosomia was associated with alterations in cholesterol metabolism through adulthood.


Subject(s)
Acetyl-CoA C-Acyltransferase/metabolism , Cholesterol 7-alpha-Hydroxylase/metabolism , Diabetes Mellitus, Experimental/metabolism , Fetal Macrosomia/metabolism , Hydroxymethylglutaryl CoA Reductases/metabolism , Liver/metabolism , Phosphatidylcholine-Sterol O-Acyltransferase/metabolism , Prenatal Exposure Delayed Effects , Acetyl-CoA C-Acyltransferase/analysis , Animals , Cholesterol/metabolism , Cholesterol 7-alpha-Hydroxylase/analysis , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/complications , Female , Growth/physiology , Hydroxymethylglutaryl CoA Reductases/analysis , Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent , Hyperglycemia/chemically induced , Hyperglycemia/metabolism , Lipoproteins/metabolism , Phosphatidylcholine-Sterol O-Acyltransferase/blood , Pregnancy , Pregnancy, Animal , Rats , Rats, Wistar , Streptozocin
12.
J Nutr ; 131(1): 39-45, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11208936

ABSTRACT

gamma-Linolenic acid [GLA, 18:3(n-6)], eicosapentaenoic acid [EPA, 20:5(n-3)] and docosahexaenoic acid [DHA, 22:6(n-3)] have been reported to prevent cardiovascular diseases. However, they are highly unsaturated and therefore more sensitive to oxidation damage. We investigated the effects of a diet rich in these polyunsaturated fatty acids (PUFA) on blood pressure, plasma and lipoprotein lipid concentrations, total antioxidant status, lipid peroxidation and platelet function in spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY). Five-week-old SHR and WKY rats were fed for 10 wk either a diet containing Isio 4 oil or a diet rich in GLA, EPA and DHA (5.65, 6.39 and 4.94 g/kg dry diet, respectively). The total antioxidant status was assayed by monitoring the rate of free radical-induced hemolysis. VLDL-LDL sensitivity to copper-induced lipid peroxidation was determined as the production of thiobarbituric acid reactive substances. After dietary PUFA supplementation, a significant decrease in blood pressure of SHR rats (-20 mm Hg) was observed and the total antioxidant status was enhanced. VLDL-LDL resistance to copper-induced peroxidation was increased in both strains. The PUFA supplementation did not change platelet maximum aggregation in SHR rats, but it decreased the aggregation speed. In hypertensive rats, GLA + EPA + DHA supplementation lowers blood pressure, enhances total anti-oxidant status and resistance to lipid peroxidation, diminishes platelet aggregation speed and lowers plasma lipid concentrations. Thus, it enhances protection against cardiovascular diseases. Therefore, nutritional recommendations for cardiovascular disease prevention should take into account the pharmacologic properties of GLA, EPA and DHA.


Subject(s)
Antioxidants/metabolism , Blood Pressure/drug effects , Dietary Fats/pharmacology , Fatty Acids, Unsaturated/administration & dosage , Hypertension/metabolism , Rats, Inbred SHR/metabolism , Animals , Docosahexaenoic Acids/pharmacology , Eicosapentaenoic Acid/pharmacology , Lipid Peroxides/antagonists & inhibitors , Lipids/blood , Platelet Aggregation/drug effects , Rats , Rats, Inbred WKY , Time Factors , gamma-Linolenic Acid/pharmacology
13.
J Lab Clin Med ; 136(6): 441-8, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11128745

ABSTRACT

The aim of this study was to determine maternal and fetal lipoprotein profiles in type 1 diabetic pregnancies differing in glycemic control. Serum lipid, apolipoprotein, and lipoprotein lipid concentrations were investigated in mothers with poorly controlled or well-controlled type 1 diabetes as reflected by hemoglobin A1c(HbA1c) concentrations performed by isolab column chromatography and in their macrosomic (body wt = 4650 +/- 90 g) or appropriate-for-gestational-age newborns (body wt = 3616 +/- 68 g), and these levels were compared with those in healthy mothers and in their control newborns (body wt = 3290 +/- 45 g). In mothers with well-controlled diabetes and in their infants, serum lipid, apolipoprotein, and lipoprotein lipid concentrations were comparable to those in control mothers and in their control newborns. Mothers with poorly controlled diabetes presented higher serum triglyceride and apoprotein B-100 (apo B-100) levels but lower apo A-I and HDL3 cholesterol and phospholipid levels as compared with control values. In their macrosomic newborns, all serum lipid, apolipoprotein, and lipoprotein lipid levels were higher than those in control newborns. Maternal HbA1c and triglyceride levels in late gestation were significant predictors of fetal lipids and lipoproteins in the poorly controlled diabetes group. In conclusion, when under good metabolic control, type 1 diabetes did not affect maternal and fetal lipid levels. However, when under poor metabolic control, type 1 diabetes is associated with maternal and fetal lipoprotein abnormalities.


Subject(s)
Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Fetal Blood/metabolism , Lipids/blood , Lipoproteins/blood , Pregnancy in Diabetics/blood , Adult , Apolipoprotein A-I/metabolism , Apolipoprotein B-100 , Apolipoproteins/blood , Apolipoproteins B/blood , Blood Glucose/metabolism , Case-Control Studies , Diabetes Mellitus, Type 1/therapy , Female , Glycated Hemoglobin/metabolism , Humans , Infant, Newborn , Pregnancy , Pregnancy in Diabetics/therapy , Triglycerides/blood
14.
Nutrition ; 16(5): 368-75, 2000 May.
Article in English | MEDLINE | ID: mdl-10793306

ABSTRACT

The effects of different proportions (10, 20, and 30%) of dietary casein or highly purified soybean protein on lipid metabolism were studied in growing Wistar rats. Hepatic, plasma and lipoprotein lipid, and protein concentrations, plasma thiobarbituric acid-reactive substance (TBARS) levels, and resistance of red blood cells against free-radical attack were determined after a 4-wk dietary regimen. Compared with the 20% casein diet, the 20% soybean protein diet exhibited similar cholesterolemia but lower plasma triacylglycerol concentrations and very-low-density lipoprotein (VLDL) particle number, as measured by diminished contents of VLDL-triacylglycerol, VLDL-protein, and VLDL-apolipoprotein (Apo) B (B-100 and B-48). The soybean protein diet raised high-density lipoprotein (HDL)(2-3) particle number, as measured by enhanced concentrations of HDL(2-3) cholesterol, HDL-phospholipid, and HDL-ApoA-I. Increasing casein or soybean protein level (from 10 to 30%) in the diet involved higher VLDL-ApoB (B-100 and B-48), indicating an increase in the number of VLDL particles. Feeding the 30% casein or 30% soybean protein diet enhanced LDL-HDL(1) cholesterol contents. Despite similar HDL(2-3)-ApoA-I levels, the 30% casein diet enhanced the HDL(2-3) mass and its cholesterol concentrations. In contrast, feeding either the 10 or 30% soybean protein diet significantly lowered HDL(2-3) cholesterol and ApoA-I levels. These effects on cholesterol distribution in lipoprotein fractions occurred despite unchanged total cholesterol concentrations in plasma. Feeding 20% soybean protein versus 20% casein involved lower plasma TBARS concentrations. Decreasing casein or soybean protein levels in the diet were associated with higher plasma TBARS concentrations and had a lower resistance of red blood cells against free-radical attack. The present study shows that dietary protein level and origin play an important role in lipoprotein metabolism and the antioxidative defense status but do not affect total cholesterol concentrations in plasma.


Subject(s)
Caseins/pharmacology , Cholesterol/blood , Dietary Proteins/pharmacology , Lipoproteins/blood , Liver/metabolism , Soybean Proteins/pharmacology , Animals , Caseins/administration & dosage , Dietary Proteins/administration & dosage , Eating , Erythrocytes/immunology , Lipid Peroxidation/drug effects , Liver/drug effects , Male , Organ Size/drug effects , Rats , Rats, Wistar , Soybean Proteins/administration & dosage , Thiobarbituric Acid Reactive Substances/metabolism , Weight Gain/drug effects
15.
Biol Neonate ; 77(1): 17-24, 2000.
Article in English | MEDLINE | ID: mdl-10658826

ABSTRACT

The aim of this work was to determine lipoprotein metabolism alterations in macrosomic newborns and to see whether these lipoprotein abnormalities are parallel or not to those found in their obese or nonobese mothers. Serum lipids, apo A-I, apo B100, lipoproteins (VLDL, LDL, HDL2, and HDL3), and LCAT activity were investigated in obese and nonobese mothers and cord blood of their macrosomic or appropriate-for-gestational-age (AGA) newborns. Serum and VLDL triglyceride concentrations were higher in obese mothers of AGA newborns than in nonobese mothers. Serum triglyceride, VLDL, and apo B100 levels were higher, while serum apo A-I and HDL2 cholesterol concentrations were lower in obese mothers of macrosomic newborns than in the other groups. In their macrosomic newborns, serum lipid, lipoprotein, apo B100, and apo A-I levels were higher as compared with those of other newborns. Macrosomic newborns of nonobese mothers had lipoprotein profiles similar to those in AGA newborns. LCAT activity was similar in both mother groups and in both newborn groups. In conclusion, maternal obesity and fetal macrosomia were associated with lipoprotein abnormalities consistent with high atherogenic risk.


Subject(s)
Fetal Macrosomia/metabolism , Lipid Metabolism , Lipoproteins/metabolism , Obesity/metabolism , Adult , Apolipoprotein A-I/blood , Apolipoprotein B-100 , Apolipoproteins B/blood , Birth Weight , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Female , Fetal Blood/chemistry , Fetal Macrosomia/blood , Gestational Age , Humans , Infant, Newborn , Lipids/blood , Lipoproteins/blood , Phosphatidylcholine-Sterol O-Acyltransferase/analysis , Pregnancy , Triglycerides/blood
16.
Br J Nutr ; 84(5): 663-71, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11177179

ABSTRACT

The time course of changes in tissue lipolytic activities was studied in young rats during the consumption of a low-protein diet containing 50 g protein/kg (40 g wheat gluten +10 g casein/kg) for 28 d followed by balanced refeeding with 200 g protein/kg (160 g wheat gluten +40 g casein/kg) for 28 d. Lipoprotein lipase (LPL) activities were compared with the values of a control group fed a balanced diet containing 200 g protein/kg for 56 d. At the end of protein malnutrition period, the epididymal fat tissue LPL activity represented 36 %, and that of heart and gastrocnemius was 44 %, of those of the control group. These differences were accompanied by lower serum- and VLDL-triacylglycerols (TAG), respectively 47.6 % and 31 % of the control group values, probably resulting from reduced synthesis of VLDL-apolipoproteins (29 % of control group values), concomitant with liver lipid accumulation (4.8-fold) and little lipid storage in epididymal fat tissue. At day 2 of refeeding, there was no significant difference in liver and epididymal fat tissue LPL activities between experimental and control rats. At the end of the refeeding period, LPL activity of epididymal fat and liver lipolytic activity had increased and became similar to control group values. The consumption of a low-protein diet prevented the increase in extrahepatic LPL activities as observed in the control group. The alterations in LPL activity suggest that a low-protein diet limits lipid storage in adipose tissue due to reduced serum VLDL-TAG availability.


Subject(s)
Diet, Protein-Restricted , Dietary Proteins/administration & dosage , Lipoprotein Lipase/metabolism , Lipoproteins, VLDL/metabolism , Liver/enzymology , Analysis of Variance , Animals , Body Weight , Lipoproteins, VLDL/blood , Male , Rats , Rats, Wistar
17.
J Clin Pathol ; 53(12): 917-23, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11265176

ABSTRACT

AIMS: To determine the effects of fetal macrosomia related to maternal type 1 diabetes on the lipid transport system. METHODS: Serum lipoprotein concentrations and composition and lecithin:cholesterol acyltransferase (LCAT) activity were investigated in macrosomic newborns (mean birth weight, 4650 g; SEM, 90) and their mothers with poorly controlled type 1 diabetes, in appropriate for gestational age newborns (mean birth weight, 3616 g; SEM, 68) and their mothers with well controlled type 1 diabetes, and macrosomic (mean birth weight, 4555 g; SEM, 86) or appropriate for gestational age (mean birth weight, 3290 g; SEM, 45) newborns and their healthy mothers. RESULTS: In mothers with well controlled type 1 diabetes, serum lipids, apolipoproteins, and lipoproteins were comparable with those of healthy mothers. Similarly, in their infants, these parameters did not differ from those of appropriate for gestational age newborns. Serum triglyceride, very low density lipoprotein (VLDL), apolipoprotein B100 (apo B100), and high density lipoprotein (HDL) triglyceride concentrations were higher, whereas serum apo A-I and HDL3 concentrations were lower in mothers with diabetes and poor glycaemic control than in healthy mothers. Their macrosomic newborns had higher concentrations in all serum lipids and lipoproteins, with high apo A-I and apo B100 values compared with appropriate for gestational age newborns. In macrosomic infants of healthy mothers, there were no significant differences in lipoprotein profiles compared with those of appropriate for gestational age infants. LCAT activity was similar in both groups of mothers and newborns. CONCLUSION: Poorly controlled maternal type 1 diabetes and fetal macrosomia were associated with lipoprotein abnormalities. Macrosomic lipoprotein profiles related to poor metabolic control of type 1 diabetes appear to have implications for later metabolic diseases.


Subject(s)
Diabetes Mellitus, Type 1/blood , Fetal Macrosomia/blood , Lipoproteins/blood , Pregnancy in Diabetics/blood , Adult , Apolipoproteins/blood , Female , Fetal Macrosomia/etiology , Humans , Infant, Newborn , Lipids/blood , Maternal-Fetal Exchange/physiology , Pregnancy
18.
Clin Sci (Lond) ; 98(1): 21-30, 2000 01.
Article in English | MEDLINE | ID: mdl-10600655

ABSTRACT

The aim of this investigation was to determine the time course of changes in serum glucose, insulin and lipid levels, as well as lipid and protein content and lipolytic activities in insulin target organs (liver, adipose tissue and muscle), in macrosomic offspring of streptozotocin-induced mildly hyperglycaemic rats. Food intake and nutritional efficiency were also evaluated. Mild hyperglycaemia in pregnant rats was induced by intraperitoneal injection of streptozotocin (40 mg/kg body weight) on day 5 of gestation. Control pregnant rats were injected with citrate buffer. At birth, macrosomic pups (birth weight >1.7 S.D. greater than the mean value for the control pups) had higher serum insulin, glucose and lipid levels than control pups. These macrosomic rats maintained accelerated postnatal growth combined with high adipose tissue weight up to 12 weeks of age. These rats were not hyperphagic; however, they had higher food efficiency and fat storage capacity with higher adipocyte lipoprotein lipase activity, which contributed to persisting obesity. Hepatic lipase activity was increased in macrosomic rats at all ages. Moreover, macrosomia was associated with metabolic disturbances that varied according to age and sex. After 1 month, several alterations observed at birth had disappeared. Serum glucose, insulin and lipid levels in male and female macrosomic rats became similar to those of their respective controls. At 2 months of age, hepatic and serum triacylglycerol levels were higher in macrosomic females than in controls. By 3 months, macrosomic rats (both males and females) had developed insulin resistance with hyperinsulinaemia, hyperglycaemia, and higher serum and hepatic lipids. In conclusion, macrosomia was associated with alterations in glucose and lipid metabolism through to adulthood. It should be considered as an important potential risk factor for obesity and its metabolic complications.


Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Experimental/complications , Insulin/blood , Lipase/metabolism , Lipids/blood , Adipose Tissue/metabolism , Animals , Diabetes Mellitus, Experimental/metabolism , Eating , Female , Fetal Macrosomia/metabolism , Lipolysis , Liver/metabolism , Male , Muscle, Skeletal/metabolism , Obesity/etiology , Obesity/metabolism , Rats , Rats, Wistar , Sex Factors , Time Factors
19.
Eur J Pediatr ; 158(9): 750-6, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10485310

ABSTRACT

The aim of this study was to determine whether macrosomia related to maternal diabetes alters lipoprotein metabolism and whether these abnormalities still persist or regress after 1 month of life. Serum lipoprotein compositions and concentrations as well as serum lipid fatty acid compositions were investigated in macrosomic infants (birth weight = 4840 +/- 105 g at term) of insulin-dependent diabetic mothers at birth and after 1 month of life, and were compared to those of control infants (birth weight = 3400 +/- 198 g at term) of healthy mothers. Compared to controls, at birth, macrosomic newborns had higher serum lipids, apolipoprotein A-I and B-100, and lipoprotein (very low density lipoprotein, low density lipoprotein, high density lipoprotein-2 and high density lipoprotein-3) levels. Higher percentages of C18:2n-6 in serum triacylglycerols, phospholipids and cholesteryl esters were also observed. At day 30, in macrosomics, serum triacylglycerol, apo B-100, very low density lipoprotein and low density lipoprotein levels were still significantly higher. C18:2n-6 and C18:3n-3 contents in serum phospholipids, triacylglycerols and cholesteryl esters were reduced while C20:4n-6 and C22:6n-3 contents in serum phospholipids and cholesteryl esters were enhanced, compared to control values. Macrosomia was associated with alterations in lipoprotein compositions and concentrations at birth, some of which persisted after 1 month of life, and might play a role in the pathogenesis of diabetes and atherosclerosis in adult life.


Subject(s)
Fetal Macrosomia/blood , Lipids/blood , Lipoproteins/metabolism , Case-Control Studies , Diabetes Mellitus, Type 1 , Fatty Acids/blood , Female , Humans , Infant, Newborn/blood , Lipoproteins/blood , Pregnancy , Pregnancy in Diabetics , Reference Values
20.
J Nutr ; 128(11): 2001-8, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9808656

ABSTRACT

This study was conducted to compare in vivo the acute effects of heated (+) and (-) gossypol cottonseed flours with those of soybean flour on lipid digestion and absorption in growing rats. Rats were fed by gastric intubation mixed [3H]-oleic acid and [14C]-triolein with heated flours or without flour (control). Lipid digestion and absorption were determined for 6 h after meal intubation. Both radioactivities recovered in gastrointestinal tract were significantly higher in rats fed (+) gossypol cottonseed flour than in all other groups. The majority of both recovered radioactivities was found in stomach contents, then in stomach wall and finally in intestinal wall. The distribution of both radioactivities at different gastrointestinal levels was similar. In stomach contents and wall, [14C]-radioactivity was primarily in triacylglycerols, but was also recovered in free fatty acids and diacylglycerols. In intestinal wall (mucosa + tunica) [3H]-radioactivity was found at greatest levels in free fatty acids, then in triacylglycerols and diacylglycerols. Greatest [14C]-radioactivity was found in triacylglycerols, then in free fatty acids, in diacylglycerols and last in phospholipids in rats fed the three flours. Therefore no quantitative differences in lipid digestion and absorption were observed among the rats fed the three flours. In conclusion, both cottonseed flours slowed lipid digestion and absorption compared with soybean flour and this delay was greater in the rats fed (+) gossypol cottonseed flour than in those fed (-) gossypol cottonseed flour. However, this inhibiting effect was probably too low to induce physiologically important effects on lipid digestion or absorption.


Subject(s)
Digestion , Glycine max , Gossypol/administration & dosage , Intestinal Absorption , Oleic Acid/metabolism , Triolein/metabolism , Animals , Carbon Radioisotopes , Cottonseed Oil , Fatty Acids, Nonesterified/metabolism , Hot Temperature , Intestinal Mucosa/metabolism , Intubation, Gastrointestinal , Kinetics , Male , Rats , Rats, Wistar , Triglycerides/metabolism , Tritium
SELECTION OF CITATIONS
SEARCH DETAIL
...